Author: Ravi Shankar

Integrated exploration model identifies multiple priority epithermal and porphyry targets across Fishpot; ~2,000-metre maiden drill program prepares for launch; Company commences trading on OTCQB under INXGF

VANCOUVER, British Columbia, Sept. 24, 2026 (GLOBE NEWSWIRE) — GoldInxs Mining Corp. (“GoldInxs,” or the “Company”) (TSXV: INXS, OTCQB: INXGF) is pleased to announce it has received results from a 53.4-line-kilometre 3D Induced Polarization (“IP”) survey, reprocessed Airborne Magnetic Survey data and a Virtual DRILL™ Elemental Harmonic Resonance (“EHR”) survey on its flagship Fishpot property in Central British Columbia. The combined results have refined multiple priority exploration targets where geophysical responses coincide with surface geology, alteration and geochemical anomalies ahead of the Company’s planned ~2,000-metre maiden drill program.

The Company is also pleased to report that its common shares have commenced trading on the OTCQB Venture Market under the symbol “INXGF“, an important step in broadening GoldInxs’ shareholder base, enhancing accessibility for U.S. investors and providing an additional platform for market visibility as the Company advances its exploration programs in British Columbia.

The integrated geophysical results identified and refined multiple chargeability, resistivity and magnetic features that correlate with existing geological, alteration and surface geochemical information, providing the Company with a more robust framework for prioritizing drill targets ahead of its planned ~2,000-metre maiden drill program. The Virtual DRILL™ Elemental Harmonic Resonance (“EHR”) survey also correlates with the updated geophysical results, resulting in robust multi-discipline exploration targets (refer to the Company’s press release dated August 17, 2026). The Company continues to plan and prepare for its inaugural drill program at Fishpot, located in the broader regional setting of Artemis Gold’s Blackwater Mine and Evolution Mining’s optioned Clisbako property, providing exposure to an active and increasingly established gold exploration region.

Key Highlights

• 53.4 line-kilometer 3D IP survey identified multiple chargeability and resistivity anomalies across the Fishpot property, including responses that correlate with existing surface geology, alteration and geochemical anomalies;
• Airborne magnetic data successfully reprocessed using Magnetization Vector Intensity (“MVI”), improving interpretation of magnetic responses in areas affected by magnetic remanence;
• Virtual DRILL™ Elemental Harmonic Resonance results correlate strongly with the existing and new data, showing its potential for use on other parts of the property;
• New geophysical information evaluated as part of an integrated exploration model combining 3D IP chargeability and resistivity responses with magnetic data, Virtual DRILL™ data, geological mapping, alteration and surface geochemistry, refining priority target zones based on areas where multiple exploration datasets converge;
• Planning and targeting continues for a ~2,000-metre maiden drill program, with drill pad locations and hole orientations being finalized based on the integrated geological and geophysical model.

3D Induced Polarization Results

In late July 2026, the Company engaged SJ Geophysics to complete a 3D IP survey on the Fishpot property. Data was acquired from July 28^th to August 19^th over 53.4 line kilometers in 8 lines overlapping with the main mineralized zones on the property. Results show large zones of subsurface resistivity and chargeability anomalies, many of which correlate with the surface geochemical anomalies and geology. Of particular note is the overlapping resistivity and chargeability anomalies that underlie the Lightening Zone, as well as the chargeability high, magnetic low zone that surrounds the previously identified magnetic high “lobe”, now known as the BullsEye target. The circular magnetic and chargeability response at BullsEye is considered a priority feature for follow-up exploration and may be consistent with geological characteristics observed in copper porphyry systems; drilling will be required to test this interpretation.

The 3D IP survey provides an important additional layer of subsurface information to complement the Company’s existing surface exploration dataset. Of particular interest are areas where IP responses coincide spatially with mapped geological contacts, alteration zones and anomalous surface geochemistry. The Company believes these areas warrant additional investigation and have contributed significantly to the prioritization of drill targets for the upcoming maiden drill program.

Magnetic Survey Reprocessing Results

The previously collected airborne magnetic, radiometric, and VLF-EM survey data obtained in 2025 was provided to in3D Geoscience Inc. who reprocessed the data using Magnetization Vector Intensity (“MVI”). MVI re-models the data to reduce the impacts of magnetic remanence, which can cause certain anomalies to be offset from their true locations. Several zones of magnetic remanence were identified in the original data and the resultant MVI model improved accuracy of the data in those areas.

Virtual DRILL™

The Company has received the results from the Virtual DRILL™ EHR survey. Several target areas have been identified which correlate to the existing and newly acquired exploration data. The Virtual DRILL™ EHR survey was completed independently of the newly acquired 3D IP and reprocessed magnetic data. Several EHR target areas subsequently demonstrated spatial correlation with the updated geophysical and existing geological datasets, providing an additional layer of target validation. The maiden drill program will provide an opportunity to test selected EHR targets against conventional geological and geophysical interpretations.

The Company has now integrated six exploration datasets at Fishpot; IP chargeability, IP resistivity, magnetic data, Virtual DRILL™ EHR results, geological mapping, alteration and surface geochemistry, to prioritize areas where multiple indicators overlap.

Figure 1: Induced Polarization Survey results showing Resistivity and Chargeability.

Figure 2: Magnetics MVI reprocessing results and Virtual Drill EHR results

Drill Planning Update

Integrating the new and reprocessed geophysical data with the existing property data has allowed the Company to refine their drill targets ahead of the maiden drill program planned for the Fishpot property. Overlapping geological surface information, including geochemistry, alteration, and geological mapping data with new and updated geophysical data has highlighted several promising surface and subsurface anomalies on the property. In light of the new anomalies, the Company has created several identified priority gold-silver epithermal target zones including the ‘Lightening’ zone, the ‘Luftballon’ zone’, the ‘Thriller’ zone, the ‘Believin’ zone, the “Southside’ zone, and a copper porphyry target called the ‘BullsEye’. Further refinement will be ongoing as it relates to specific drill pad locations until drilling commences, and modifications may be made as the drill program progresses.

• Lightening Zone: Resistivity and chargeability IP anomaly overlain by intense silica alteration and overlapping geochemical anomalies.
• Luftballon Zone: Magnetic low with a moderate chargeability anomaly located north of the magnetic high lobe. Intense silica alteration with overlapping geochemical anomalies.
• Thriller Zone: Magnetic low zone with resistivity anomaly, silica “ribs” present on surface.
• Believin’ Zone: Resistivity high zone with moderate chargeability anomaly and overlapping magnetic low.
• Southside Zone: Moderate chargeability high with resistivity high contact, south side of the circular magnetic lobe.
• BullsEye: Magnetic high zone surrounded by magnetic low with moderate chargeability anomaly.

Figure 3: Fishpot exploration target areas

The maiden drill program is being designed to test multiple geological and geophysical targets across the property and provide the Company with its first systematic subsurface drilling dataset at Fishpot. Results from the drill program are expected to provide important information regarding geometry, continuity, geological controls and potential scale of mineralized systems identified through surface exploration and geophysical interpretation.

Millar Property

GoldInxs has decided to drop its interests in the Millar Property in order to focus resources on its core, road accessible and drill ready Fishpot Project given the near-term catalysts and discovery potential. The Company is actively pursuing other acquisitions of properties in North America.

Nick Michael, President and CEO of GoldInxs, commented:

“The Induced Polarization results represent one of the final pieces of information needed to further refine our drill targeting. The data has identified several compelling targets and strengthened our confidence in the areas we have prioritized for drilling. Most importantly, we are seeing strong convergence across multiple exploration datasets, allowing us to move from broad target generation to a focused maiden drill program designed to test some of the most compelling targets identified at Fishpot.The commencement of trading on the OTCQB is also an important corporate milestone for GoldInxs, supporting and improving the Company’s visibility and liquidity. It expands the Company’s accessibility to U.S. investors at an exciting stage in our exploration program, as we transition from systematic target generation toward the first drill testing at Fishpot.”

Qualified Person

The technical information contained in this news release has been reviewed and approved by Darcy Vis, P.Geo., the Qualified Person for GoldInxs Mining Corp., who is responsible for the technical information contained herein. The Company’s corporate presentation identifies Mr. Vis as the Qualified Person responsible for the technical information presented by GoldInxs.

Authorised for release by the Board of GoldInxs Mining Corp.

About GoldInxs

GoldInxs Mining Corp. (TSXV:INXS, OTCQB: INXGF) is a Canadian mineral exploration company focused on discovering and advancing a high-quality gold and copper project in Central British Columbia. The Company’s flagship asset is the Fishpot Property, a large epithermal gold system in central British Columbia with Blackwater-style exploration potential, and in the same region as Artemis Gold’s Blackwater Mine and Evolution Mining’s optioned Clisbako property. The Company is listed on the TSX Venture Exchange under the symbol INXS and on the OTCQB Venture Market under the symbol INXGF, and is led by an experienced management and technical team committed to disciplined exploration and value creation for shareholders.

Website: www.goldinxs.com      |     LinkedIn: LINK      |     Twitter/X: LINK

Further Information:

Barry Miller                        
Executive Chairman and Director
GoldInxs Mining Corp.
T: 778.232.1878
E: barry@goldinxs.com

Forward-Looking Statements

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively referred to herein as “forward-looking statements”) within the meaning of applicable securities legislation. Such forward-looking statements are based on a number of assumptions, which may prove to be incorrect. Assumptions have been made regarding, among other things: conditions in general economic and financial markets; accuracy of assay results; geological interpretations from exploration, survey, historic work, drilling results, timing and amount of capital expenditures; performance of available laboratory and other related services; future operating costs; and the historical basis for current estimates of potential quantities and grades of target zones. The actual results could differ materially from those anticipated in these forward-looking statements as a result of risk factors, including the timing and content of work programs; results of exploration activities and development of mineral properties; the interpretation and uncertainties of drilling results and other geological data; receipt, maintenance and security of permits and mineral property titles; environmental and other regulatory risks; project costs overruns or unanticipated costs and expenses; availability of funds; failure to delineate potential quantities and grades of the target zones based on historical data; and general market and industry conditions.

Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. Forward-looking statements in this news release include, but are not limited to, statements regarding the Company’s planned exploration activities at the Fishpot Property or any other Company properties, the timing, scope and objectives of the planned maiden drill program, the anticipated usefulness of geological, geochemical and geophysical data in refining exploration targets, potential exploration results, other prospective exploration projects, regional considerations, potential future financings of the Company and the potential benefits of the Company’s listing on the OTCQB Venture Market.

The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made. The Company undertakes no obligation to update or revise any forward-looking statements included in this news release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/bfe5c0b8-9313-45b3-b711-262ed618d0b8

https://www.globenewswire.com/NewsRoom/AttachmentNg/2ed00ce5-97be-4d3b-9605-544a5458b544

https://www.globenewswire.com/NewsRoom/AttachmentNg/be70e054-86fd-4d61-991f-119a8edb9357 

NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received approval from the United States Food and Drug Administration (FDA) to implement a new potency assay, T-cell Proliferation Inhibition BioAssay (TIBA), for release and stability monitoring of all new commercial product lots of its FDA-approved mesenchymal stromal cell (MSC) product Ryoncil^® (remestemcel-L-rknd).

The TIBA assay will ensure sufficient sensitivity to detect any shifts in potency of the commercial product that could arise during changes in manufacturing processes or production in new facilities. This assay will be used as part of a matrix to release each commercial batch of RYONCIL in conjunction with the existing potency assays which determine IL-2Rα inhibition and CAP (Cell Adhesion and Proliferation), as per the product’s Biologics License. Together these assays ensure that the RYONCIL product is consistent, potent, and clinically effective.

RYONCIL is the first industrially-manufactured allogeneic MSC product approved by FDA for any indication, and the only MSC product to be approved for patients with steroid-refractory acute graft versus host disease (SR-aGvHD) aged 2 months or older.¹ Mesoblast and FDA have been working closely together since RYONCIL was approved for commercial use to ensure alignment on continued advancements to the product’s manufacturing processes and implementation of assays measuring the product’s ongoing quality control.

About Mesoblast
Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The therapies from the Company’s proprietary mesenchymal lineage cell therapy technology platform respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant reduction of the damaging inflammatory process.

Mesoblast’s Ryoncil^® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved mesenchymal stromal cell (MSC) therapy. Please see the full Prescribing Information at www.ryoncil.com.

Mesoblast is committed to developing additional cell therapies for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Ryoncil^® is being developed for additional inflammatory diseases including SR-aGvHD in adults and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for heart failure and chronic low back pain. The Company has established commercial partnerships in Japan, Europe and China.

About Mesoblast intellectual property: Mesoblast has a strong and extensive global intellectual property portfolio, with over 1,000 granted patents or patent applications covering mesenchymal stromal cell compositions of matter, methods of manufacturing and indications. These granted patents and patent applications provide commercial protection extending through to at least 2044 in all major markets.

About Mesoblast manufacturing: The Company’s proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide.

Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see www.mesoblast.com, LinkedIn: Mesoblast Limited and X: @Mesoblast

Footnotes / References

1. Please see the full Prescribing Information at www.ryoncil.com

Forward-Looking Statements
This press release includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements should not be read as a guarantee of future performance or results, and actual results may differ from the results anticipated in these forward-looking statements, and the differences may be material and adverse. Forward-looking statements include, but are not limited to, statements about: the initiation, timing, progress and results of Mesoblast’s preclinical and clinical studies, and Mesoblast’s research and development programs; Mesoblast’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; Mesoblast’s ability to advance its manufacturing capabilities; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities, if any; the commercialization of Mesoblast’s RYONCIL for pediatric SR-aGVHD and any other product candidates, if approved; regulatory or public perceptions and market acceptance surrounding the use of stem-cell based therapies; the potential for Mesoblast’s product candidates, if any are approved, to be withdrawn from the market due to patient adverse events or deaths; the potential benefits of strategic collaboration agreements and Mesoblast’s ability to enter into and maintain established strategic collaborations; Mesoblast’s ability to establish and maintain intellectual property on its product candidates and Mesoblast’s ability to successfully defend these in cases of alleged infringement; the scope of protection Mesoblast is able to establish and maintain for intellectual property rights covering its product candidates and technology; estimates of Mesoblast’s expenses, future revenues, capital requirements and its needs for additional financing; Mesoblast’s financial performance; developments relating to Mesoblast’s competitors and industry; and the pricing and reimbursement of Mesoblast’s product candidates, if approved. You should read this press release together with our risk factors, in our most recently filed reports with the SEC or on our website. Uncertainties and risks that may cause Mesoblast’s actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements, and accordingly, you should not place undue reliance on these forward-looking statements. We do not undertake any obligations to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

Release authorized by the Chief Executive.

For more information, please contact:

Corporate Communications / Investors
Paul Hughes
T: +61 3 9639 6036
Media – Global	Media – Australia
Rubenstein	BlueDot Media
Caroline Nelson	Steve Dabkowski
T: +1 703 489 3037	T: +61 419 880 486
E: cnelson@rubenstein.com	E: steve@bluedot.net.au

To Nasdaq Copenhagen

FIXING OF COUPON RATES        24 September 2026

Fixing of coupon rates effective from 1 October 2026

Effective from 1 October 2026, the coupon rates of floating-rate bonds issued by Nykredit Realkredit A/S and Totalkredit A/S will be adjusted.

Bonds with quarterly interest rate fixing
The new coupon rates will apply from 1 October 2026 to 31 December 2026:

Uncapped bonds
DK0009518896, (32H), maturity in 2027, new rate as at 1 October 2026: 2.8422% pa
DK0009546087, (32H), maturity in 2027, new rate as at 1 October 2026: 2.7408% pa
DK0009546160, (32H), maturity in 2027, new rate as at 1 October 2026: 2.7307% pa
DK0009546244, (32H), maturity in 2027, new rate as at 1 October 2026: 2.7104% pa
DK0009546327, (32G), maturity in 2027, new rate as at 1 October 2026: 2.7713% pa
DK0009547721, (32H), maturity in 2027, new rate as at 1 October 2026: 2.8422% pa
DK0009548026, (32G), maturity in 2027, new rate as at 1 October 2026: 2.8524% pa
DK0009548109, (32H), maturity in 2028, new rate as at 1 October 2026: 2.8220% pa
DK0009548299, (32H), maturity in 2028, new rate as at 1 October 2026: 2.8118% pa
DK0009549859, (32H), maturity in 2029, new rate as at 1 October 2026: 2.8017% pa
DK0009549933, (32H), maturity in 2029, new rate as at 1 October 2026: 2.8118% pa
DK0009550006, (32G), maturity in 2028, new rate as at 1 October 2026: 2.8220% pa
DK0009551244, (32H), maturity in 2027, new rate as at 1 October 2026: 2.7915% pa
DK0009551400, (32H), maturity in 2028, new rate as at 1 October 2026: 2.6800% pa
DK0009551590, (32H), maturity in 2029, new rate as at 1 October 2026: 2.7408% pa
DK0009551673, (32H), maturity in 2029, new rate as at 1 October 2026: 2.6800% pa
DK0009551756, (32H), maturity in 2028, new rate as at 1 October 2026: 2.7104% pa
DK0009551913, (32H), maturity in 2030, new rate as at 1 October 2026: 3.1370% pa
DK0009552135, (32H), maturity in 2028, new rate as at 1 October 2026: 2.8017% pa
DK0009553885, (32H), maturity in 2029, new rate as at 1 October 2026: 2.6293% pa
DK0009553968, (32H), maturity in 2029, new rate as at 1 October 2026: 2.6293% pa
DK0009554180, (32H), maturity in 2029, new rate as at 1 October 2026: 2.6395% pa
DK0009554263, (32H), maturity in 2029, new rate as at 1 October 2026: 2.6395% pa
DK0009554503, (32H), maturity in 2030, new rate as at 1 October 2026: 3.0660% pa
DK0009554776, (32H), maturity in 2030, new rate as at 1 October 2026: 2.7408% pa
DK0009555740, (32H), maturity in 2028, new rate as at 1 October 2026: 2.6293% pa
DK0009766446, (49D), maturity in 2038, new rate as at 1 October 2026: 2.6395% pa
DK0009769622, (21E), maturity in 2041, new rate as at 1 October 2026: 2.6395% pa

Questions may be directed to Investor Relations at investor_relations@nykredit.dk or Press Officer Peter Klaaborg, tel +45 44 55 14 94.

Attachment

• Fixing of coupon rates – Nykredit Realkredit – 20260924

Descartes Datamyne™ AI Agent draws on data spanning 230 markets with more than 500 million shipment records annually to deliver traceable insights in seconds 

LONDON and ATLANTA, Sept. 24, 2026 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced the Descartes Datamyne™ AI Agent, a new conversational AI capability that helps sourcing, sales, supply chain and market intelligence teams reduce global trade data research and analysis time by up to 90%, depending on the user’s experience and query complexity. Embedded in the Descartes Datamyne global trade intelligence solution, the AI Agent allows users to ask questions in natural language and returns contextual answers in seconds, supported by dynamic visualizations and the underlying shipment records.

“Geopolitical disruption, tariff volatility and shifting sourcing patterns are making trade decisions more complex and time-sensitive,” said Brian Hodgson, General Manager, Trade Intelligence at Descartes. “By making trusted trade intelligence more accessible, the Descartes Datamyne AI Agent helps organizations understand where suppliers are gaining or losing activity, how product flows are changing, where market demand is emerging and how competitors are adapting. Users move quickly from a business question to validated insights on trends, risks and opportunities while retaining visibility into the records behind the analysis.”

Descartes Datamyne covers 230 markets with more than 500 million shipment records added annually. The AI Agent makes this extensive import and export data foundation easier to access, helping users identify suppliers, monitor competitors, evaluate trade risks, develop sales opportunities, and understand changing markets. In seconds, it responds to natural-language questions with relevant data, visualizations and contextual insights.

The Descartes Datamyne AI Agent helps users:

• Ask complex trade questions in natural language without building filters, using Boolean logic or mastering database query structures;
• Validate AI-generated findings through dynamically updated data views, visualizations and drill-down access to supporting shipment records;
• Explore insights within the same environment by refining questions and investigating related companies, commodities, shipments and trade relationships;
• Analyze actual trade behavior using observed shipment activity to understand changes in suppliers, buyers, product flows and market demand, rather than company descriptions, self-reported supplier profiles or general web content; and
• Improve supply chain planning with decision-ready summaries that highlight notable trends, anomalies, sourcing opportunities and other patterns across large volumes of trade records.

“AI is most useful when it combines trusted, domain-specific data with a clear connection to the decisions customers need to make,” said Ken Wood, EVP Product Management at Descartes. “The Agent analyzes shipment-level data and presents findings alongside the records and visual evidence supporting them, allowing users to verify conclusions, refine their questions and continue exploring without leaving the platform. Embedding the Agent directly into Descartes Datamyne gives customers a more transparent and intuitive way to accelerate decision-making and respond more effectively to changing global trade conditions.”

Learn more about the Descartes Datamyne AI Agent and Descartes’ Global Trade Intelligence solutions.

About Descartes

Descartes powers more responsive, efficient, secure and sustainable international and domestic supply chains by uniting logistics-intensive businesses on its Global Logistics Network (GLN). Shippers, carriers, and logistics service providers connect and collaborate on the GLN leveraging technology, data and AI to manage last mile deliveries, domestic and international shipments, transportation rating and payment, global trade research, customs compliance and a variety of regulatory processes. Learn more about Descartes at www.descartes.com and connect with us on LinkedIn and X.

Global Media Contact
Cara Strohack                                                                     
Tel: 226-750-8050                                 
cstrohack@descartes.com  

Cautionary Statement Regarding Forward-Looking Statements

This release contains forward-looking information within the meaning of applicable securities laws (“forward-looking statements”) that relate to Descartes’ global trade intelligence solution offerings and potential benefits derived therefrom, and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, “Certain Factors That May Affect Future Results” in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities regulatory authorities across Canada including Descartes’ most recently filed annual and interim management’s discussion and analysis which are available under Descartes’ profile through the EDGAR website at http://www.sec.gov or through the SEDAR+ website at http://www.sedarplus.com/. If any such risks actually occur, they could, among other consequences, materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. Except as required by applicable law, we do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:	Investec Bank plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	Pollen Street Group Limited
(c)        Name of the party to the offer with which exempt principal trader is connected:	Investec is Joint Broker to Pollen Street Group Limited
(d)        Date dealing undertaken:	23rd September 2026
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or possible cash offer, state “N/A”	N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security	Purchases/ sales	Total number of securities	Highest price per unit paid/received	Lowest price per unit paid/received
Ordinary shares	Purchases	7,139	957.05	863
Ordinary shares	Sales	11,818	954.5	835

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
N/A	N/A	N/A	N/A	N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit
N/A	N/A	N/A	N/A	N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
N/A	N/A	N/A	N/A

3.        OTHER INFORMATION
        
(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)        the voting rights of any relevant securities under any option; or (ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

Date of disclosure:	24th September 2026
Contact name:	Priyali Bhattacharjee
Telephone number:	+91-9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:	Investec Bank Plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	SThree Plc
(c)        Name of the party to the offer with which exempt principal trader is connected:	Investec is Joint Broker to SThree Plc
(d)        Date dealing undertaken:	23rd September 2026
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or possible cash offer, state “N/A”	N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security	Purchases/ sales	Total number of securities	Highest price per unit paid/received	Lowest price per unit paid/received
Ordinary shares	Purchases	165,725	313.5	306
Ordinary shares	Sales	181,587	313.5	306

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
N/A	N/A	N/A	N/A	N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit
N/A	N/A	N/A	N/A	N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
N/A	N/A	N/A	N/A

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)        the voting rights of any relevant securities under any option; or (ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

Date of disclosure:	24th September 2026
Contact name:	Priyali Bhattacharjee
Telephone number:	+91-9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.

Transaction is structured around a negotiated $0.0004 per-share BFCH reference value and is intended to establish a controlled public health, wellness, longevity and human-optimization platform

GREEN VALLEY, Ariz., Sept. 24, 2026 (GLOBE NEWSWIRE) — NEXT10, Inc. (OTC: NXTN) (“NEXT10” or the “Company”), through Torreon Group, Inc., today announced today announced that it has entered into a binding Letter of Intent with BitFrontier Capital Holdings, Inc. (OTCID: BFCH), a public company doing business as UNLOCKD, Inc., for a strategic transaction intended to expand NEXT10’s operating platform.

Under the LOI, the parties agreed to use $0.0004 per issued and outstanding BFCH common share as the negotiated reference value for structuring the transaction.

Subject to completion of the required closing conditions, NEXT10 is expected to contribute agreed operating businesses and assets to BFCH and ultimately acquire approximately 75% ownership of BFCH.

The $0.0004 figure is a negotiated transaction value only. It is not an independent appraisal or fairness opinion and should not be interpreted as a prediction of BFCH’s current or future trading price.

Expanding NEXT10’s Operating Platform

NEXT10 is pursuing a strategy centered on acquiring, developing and operating businesses and strategic assets across multiple sectors.

The contemplated transaction is designed to give NEXT10 a controlled public subsidiary focused on health, wellness, longevity and human optimization, while providing BFCH access to additional operating assets, management resources and acquisition capabilities.

“I have had a personal interest in regenerative medicine and the broader wellness industry for some time, and I have been evaluating wellness centers in Florida as potential acquisition opportunities,” said Garrett Reincke, President of NEXT10, Inc. “I believe regenerative medicine and advanced wellness services fit naturally within the broader health, longevity and human-optimization strategy BFCH is building. This transaction gives us a platform to evaluate those opportunities more seriously and, where the economics and operations make sense, potentially expand into that market.” 

Reincke continues, “NEXT10 is entering the sector amid continued growth in global consumer spending on wellness. According to the Global Wellness Institute, the global wellness economy reached approximately $6.8 trillion in 2024 and is projected to approach $9.8 trillion by 2029. The United States represents the world’s largest wellness market, estimated at approximately $2.1 trillion in 2024.” 

Transaction Structure

The transaction is expected to occur in stages.

At the Initial Closing, NEXT10 is expected to contribute agreed operating businesses and assets to BFCH, acquire a noncontrolling equity interest and receive representation on the BFCH Board of Directors.

The specific businesses and assets to be contributed remain subject to final designation, due diligence and definitive transaction documentation.

BFCH will also continue working toward completion of its planned independent audit.

Following completion of the audit, due diligence, definitive documentation and other closing conditions, NEXT10 is contemplated to increase its ownership position to approximately 75% of BFCH.

The parties currently intend for BFCH to remain a separately traded public company following completion of the transaction.

Strategic Alignment

BFCH, doing business as UNLOCKD, has been developing a health and wellness portfolio that currently includes Ancient Extracts, EVERMIND and 1ENERGY.

Its broader strategy is focused on health, wellness, longevity and human optimization.

The proposed transaction is intended to combine that focused platform with NEXT10’s broader operating, acquisition and asset-development capabilities.

“This is an important next step in the strategy we have been building at BFCH,” said Dr. Jordan P. Balencic, Chairman and Chief Science Officer of BFCH. “Our goal is to build a larger operating company around health, wellness, longevity and human optimization. I expect the NEXT10 relationship to rapidly expand our core mission and is intended to give us additional assets, resources and capabilities to pursue that strategy at greater scale.”

Building a Broader Health and Wellness Business

BFCH’s strategy is focused on identifying businesses and assets that management believes may benefit from additional capital, stronger operations, product development, brand optimization and expanded distribution.

NEXT10 believes the relationship could broaden the range of opportunities available to BFCH across consumer products, wellness services, technology, testing, distribution and related businesses.

The transaction also aligns with NEXT10’s broader acquisition strategy of identifying operating businesses and assets where additional capitalization, operational discipline and active management may create opportunities for growth and increased enterprise value.

About NEXT10, Inc.

NEXT10, Inc. (OTC: NXTN) is a diversified public company pursuing growth through operating businesses, strategic investments, asset development and acquisitions across multiple sectors.

The Company’s strategy is to identify businesses and assets where additional capitalization, operating discipline and active management may improve operations, generate cash flow and create long-term enterprise value.

About BitFrontier Capital Holdings, Inc. / UNLOCKD

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD, Inc., is building a diversified health, wellness and consumer platform focused on acquiring, developing and commercializing brands and businesses across consumer health, wellness, longevity and human optimization. You can learn more about or strategy at www.unlockdinc.com

The Company’s current portfolio includes Ancient Extracts, EVERMIND and 1ENERGY.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the contemplated transaction between NEXT10 and BFCH, the contribution of businesses and assets, the Initial Closing, the contemplated change of control, future ownership percentages, BFCH’s planned audit, potential OTCQB qualification and future business opportunities.

Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially.

Although NEXT10 and BFCH have entered into a binding Letter of Intent, completion of the transaction remains subject to due diligence, definitive documentation, corporate approvals, accounting and financial-statement requirements, regulatory considerations and other closing conditions. There can be no assurance that the Initial Closing or contemplated change of control will occur on the proposed terms or at all.

The $0.0004 per-share amount is a negotiated transaction reference value used by the parties to structure the transaction. It is not an independent appraisal or fairness opinion and does not represent a guarantee or prediction of BFCH’s current or future market price.

There can be no assurance that BFCH will complete its audit, qualify for OTCQB or successfully complete any future acquisition, financing or strategic initiative.

Readers should not place undue reliance on forward-looking statements. NEXT10 undertakes no obligation to update or revise them except as required by applicable law.

Contact

John B. Hayden
CEO/CHAIRMAN
TORREON GROUP INC./NEXT10
ir@torreongroupinc.com

Highlights Strong Progress Against VISION 2027 Strategic Growth Plan

COSTA MESA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) hosted its first Investor Day event in nearly four years. Chairman, President, and CEO Stephen G. Oswald and his senior leadership team briefed attendees on the exciting progress that the Company has made against its five-year strategic growth plan, VISION 2027. Ducommun is on track to meet or exceed all three core metrics of the current plan despite pressures facing the aerospace and defense industry.

Having established a strong foundation for continued growth, Oswald unveiled VISION 2032, which aims to accelerate innovation and efficiencies in the American aerospace and defense supply chain.

“Ducommun has contributed to some of the most important technologies in aerospace and defense,” said Oswald. “With our strong position in defense, improvement in commercial aerospace, and expanding portfolio of proprietary engineered products, we are well positioned not just to drive substantial shareholder value through 2032, but to reinforce the strengths and resilience of American aerospace and defense.”

Coming out of the Covid pandemic, Ducommun set ambitious business targets for revenue growth and margin expansion in VISION 2027 (announced in December 2022). Performance against key metrics has been strong, with Ducommun delivering total shareholder return of 245% since the end of 2022.

Delivering on VISION 2027 Objectives
At Investor Day, Oswald highlighted significant progress toward its VISION 2027 goals, confirming that the Company remains on track to meet or exceed all three core financial targets set in 2022:

• Revenue: Reaching ~$950M+ by 2027.
• Profitability: Expanding Adjusted EBITDA margins to ~18%.
• Engineered Products Mix: Increasing higher-margin Engineered Products (EP) to ~25% of total revenue.

These achievements have significant real-world implications: strengthening frontline military technologies and supporting commercial aviation safety as a U.S.-based manufacturer.

Over the last four years, Ducommun’s market capitalization has increased from $605 million to $2.6 billion, while average daily traded value of the Company’s stock has increased from ~$2 million to $49 million during the same period. Through a series of strategic acquisitions in recent years, including companies specializing in magnetic seals, ammunition handling systems, lightning protection, thermoplastic extrusions and aerodynamic systems, Ducommun has been able to expand its portfolio of Engineered Products and Aftermarket content for customers.

Unveiling the VISION 2032 Growth Roadmap
Building on this solid foundation, Ducommun announced its VISION 2032 plan, which sets a combination of ambitious strategic catalysts and long-term financial goals to power the Company’s upward trajectory:

• M&A Strategy: Capitalizing on Equity Valuation Growth and Balance Sheet Strength, Ducommun is increasing its acquisition range by up to 3–5x, pursuing acquisition targets in the $300M to $500M range while continuing to pursue bolt-on acquisitions as well.
• Defense Franchise Expansion: The company projects a mid-teens compound annual growth rate (CAGR) through 2032 for its core missile and radar franchise.
• Commercial Aerospace Rebound: Ducommun is positioned to capture commercial aerospace volume recovery across major narrowbody platforms with minimal required capital expenditure.
• Proprietary Engineered Products: Continued organic investment in proprietary technologies will reinforce value pricing power and competitive differentiation.

Several analysts in attendance at Investor Day commented positively on Ducommun’s performance and long-term growth strategy. Analysts from Citi stated that Ducommun “surpassed both our and consensus expectations.” RBC highlighted the company’s “impressive set of 2032 targets.” Goldman Sachs, meanwhile, noted: “DCO has unique positions on growth verticals with A&D (missile, aero OE, aftermarket), multiple company-specific margin drivers, and an acquisition platform, all under the umbrella of company transformation . . . we are Buy rated on the stock.”

The full Investor Day presentation is available on Ducommun’s Investor Relations site.

About Ducommun Incorporated
Ducommun Incorporated delivers value-added innovative products, aftermarket and manufacturing solutions to customers in the aerospace, defense and space markets and aspires to contribute to the advancement of those industries. Founded in 1849, the Company specializes in two core areas — Electronic Systems and Structural Systems — to produce complex products and components for commercial aircraft platforms and mission-critical military and space programs. For more information, visit Ducommun.com.

Forward-Looking Statements
This press release includes “forward looking statements” within the meaning of the federal securities laws relating to Ducommun Incorporated, including statements relating to Ducommun’s expectations relating to the Company’s VISION 2027 Strategy and its progress towards the financial goals stated therein, including but not limited to those relating to revenues, profitability and our Engineered Products’ mix; our acquisition strategy, the expected compound annual growth rate and expansion of the Company’s defense portfolio, the ability to capture volume through the commercial aerospace recovery, our expected investment in proprietary technologies to reinforce value pricing power and competitive differentiation, expectations relating to expanding production capacity and ability to drive shareholder value, all under our VISION 2032 game plan for investors , and similar expressions that concern Ducommun’s intentions or beliefs about future occurrences, expectations, or results. Forward-looking statements are subject to risks, uncertainties and other factors that may change over time and may cause actual results to differ materially from those that are expected. It is very difficult to predict the effect of known factors, and Ducommun cannot anticipate all factors that could affect actual results that may be important to an investor. All forward-looking information should be evaluated in the context of these risks, uncertainties and other factors, including those factors disclosed under “Risk Factors” in Ducommun’s reports filed with the SEC, including the Company’s Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, and Current Reports on Form 8-K. The forward-looking statements included in this press release are made only as of the date of this press release, and Ducommun does not undertake any obligation to (and expressly disclaims any such obligation to) update the forward-looking statements to reflect subsequent events or circumstances.

Contacts
Suman Mookerji, Senior Vice President and Chief Financial Officer
657.335.3665, SMookerji@ducommun.com 

Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care Organizations

DETROIT, Sept. 24, 2026 (GLOBE NEWSWIRE) — Amesite Inc. (Nasdaq: AMST), an adaptive AI technology company and developer of the AI-native NurseMagic^® documentation platform and LynkMagic™ enterprise solutions, today announced a new sales win with its minimum enterprise pricing model, providing additional commercial validation for a model designed to serve post-acute care organizations across a broad range of operating sizes while supporting attractive unit economics and scalable revenue growth.

Under the new model, NurseMagic^® Enterprise is priced at $1,099 per month for organizations with patient census up to 1,000 under a 12-month contract. Amesite estimates annual agreements at this level provide approximately 85% gross margin, establishing meaningful contract value at smaller census levels while preserving greater revenue opportunity as deployment size increases.

The agreement builds on previously announced NurseMagic^® commercial milestones, including a 2.4x sequential quarterly revenue increase, 63% revenue growth from NurseMagic^® Enterprise and an approximately 2,700-patient census enterprise deployment, the Company’s largest announced deployment to date.

Amesite believes that the pricing model creates a repeatable commercial sale for smaller post-acute care organizations while allowing it to remain focused on larger multi-location and multi-state enterprises representing substantially greater census and revenue opportunities. Recent customer wins did not require customers to replace their existing EMRs or undertake a rip-and-replace technology implementation.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “We made a deliberate decision to set a minimum enterprise price that works for Amesite and still delivers tremendous value to customers. At $1,099 per month for organizations with up to 1,000 census, we can serve smaller operators at attractive margins without building our business around small contracts. At the same time, our census-based pricing gives us significantly greater revenue opportunity as we win larger organizations. We believe this model enables us to generate returns on our technology investments.”

Sai Nittala, Amesite’s Head of Artificial Intelligence, said, “We designed this pricing structure to create a repeatable commercial model for smaller post-acute care organizations while maintaining attractive unit economics. Establishing a clear minimum enterprise price has helped us streamline sales and advance scalable revenue growth.”

Kalie Wortinger, Amesite’s Head of Engineering, said “Our recent sales wins have not required customers to replace their existing EMRs. As we expand the number of EMR environments NurseMagic^® supports, we can serve a broader portion of the post-acute care market. That interoperability reduces deployment friction and supports our ability to scale across customer environments.”

About Amesite Inc.

Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic^®, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic^® is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic^® meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages.

Forward-Looking Statement

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company and its business. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations

ir@amesite.com

Extended drilling adds a new skarn horizon beneath the previously reported down-dip extension

VANCOUVER, British Columbia, Sept. 24, 2026 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to provide an update on ongoing diamond drilling at the Company’s 100%-owned Magno Project in the Cassiar District of northern British Columbia.

Further to the Company’s September 15, 2026, drilling update, GoldHaven reports that GOH26-04 has now been completed following an extension of the hole beyond its originally planned termination depth. Continued drilling intersected a newly identified skarn zone beneath the down-dip extension described in the September 15 release. The drill has since been moved to a new pad (Pad B) at the Kuhn target, where three of the holes have been completed and drilling of the fourth from Pad B is underway.

Highlights

• GOH26-04 has been completed after being extended beyond its originally planned termination depth.
• Continued drilling intersected a new skarn zone beneath the previously reported down-dip extension at Kuhn.
• Drilling encountered a series of stockwork skarn mineralization zones from approximately 235 to 325m (drill length), followed by more continuous skarn mineralization from 345 to 400m.
• The newly identified intervals total approximately 145 metres of drill length, with true thickness currently interpreted at approximately 40-45 metres.
• The drill has now moved to a new pad at Kuhn and commenced drilling, continuing the systematic testing of the skarn system.

GOH26-04 Extended Following Geological Review

GOH26-04 was designed to test the down-dip continuation of the historically identified skarn system at Kuhn. Following review of the drill core by GoldHaven’s geological team, observations within the hole were considered sufficiently encouraging to warrant continuing drilling beyond the originally planned termination depth.

The decision resulted in the intersection of an additional skarn zone beneath the down-dip extension previously identified in GOH26-04.

Figure 1: Drill core from GOH26-04 at approximately 164–166m depth, showing skarn with locally semi-massive sulphide mineralization. The Company is continuing to log, sample and submit core for laboratory analysis.

The newly identified skarn intervals total approximately 145 metres of drill length. Based on the Company’s current geological interpretation, true thickness is estimated at approximately 40–45 metres, assuming the newly identified lower zone dips at a similar angle to the overlying stratigraphy and skarn units. This interpretation is preliminary and may be refined as additional geological and drilling information becomes available.

The skarn intervals display several mineralization styles, including magnetite skarn, garnet skarn, diopside skarn, and zones of semi-massive to massive sulphide mineralization. The skarnified intervals are hosted within a sequence of limestone, marble and dolomite.

The Company is continuing to log, photograph and sample the drill core, with samples being submitted for laboratory analysis. The September 15 release noted that core from the Kuhn program was being logged and sampled, with assays to be released once received, reviewed and verified.

Figure 2: 2026 diamond drilling from Pad B at the Kuhn target, Magno Project.

Expanding the Geological Picture at Kuhn

The ongoing drill program is designed to improve GoldHaven’s understanding of the geometry, thickness and continuity of the skarn system through a series of modern drill sections across the Kuhn target.

The additional skarn encountered in GOH26-04 provides another important geological data point as the Company evaluates the development of the system beyond areas tested by historical drilling.

GoldHaven’s 2026 program represents the Company’s first modern, systematic drill campaign at Magno, with drilling initially focused on Kuhn before evaluating additional priority targets across the broader property.

CEO Comment

GoldHaven President and CEO Rob Birmingham commented:

“The decision to continue GOH26-04 was driven directly by what our geological team was seeing in the core, and that decision has now resulted in the intersection of an additional skarn zone beneath the down-dip extension we reported last week.

“We are encouraged to continue seeing skarn development as we test the Kuhn system at depth. While assays will ultimately determine the significance of these intervals, each hole is materially improving our understanding of the geometry and scale of the system and helping us refine where we drill next.”

Ongoing Drill Program

With GOH26-04 now complete, the drill has been moved to a new pad (Pad B) at the Kuhn target where three of the four planned drill holes have been completed.

Integration of observations from the latest drill holes, notably GOH26-04, historical geological information and modern geophysical data to refine subsequent drill targeting remains ongoing.

Further updates will be provided as drilling advances and laboratory results are received, reviewed and verified.

Qualified Person

The technical and scientific information contained in this news release has been reviewed and approved by Raymond Wladichuk, P.Geo. B.Sc., a non-independent Qualified Person as defined under NI 43-101, a BC Licensed professional, and a consultant to the Company.

About GoldHaven Resources Corp.

GoldHaven Resources Corp. is a Canadian junior exploration company focused on advancing highly prospective mineral projects in North and South America. The Company’s flagship asset is the district-scale Magno Project in the Cassiar District of northern British Columbia. GoldHaven also owns the Three Guardsmen Copper-Gold Project in British Columbia and the Copeçal Gold Project in Mato Grosso, Brazil. In addition, the Company holds a portfolio of critical mineral projects in Brazil.

On Behalf of the Board of Directors

Rob Birmingham, Chief Executive Officer

For further information, please contact:
Rob Birmingham, CEO
www.GoldHavenresources.com
info@goldhavenresources.com
Office Direct: (604) 629-8254

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE – Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward-Looking Information

This news release contains forward-looking statements and forward-looking information (collectively, “forward- looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included herein including, without limitation, those listed below under the heading “Forward-Looking Statements in This News Release” are forward-looking statements. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: “believes”, “will”, “expects”, “anticipates”, “intends”, “estimates”, “plans”, “may”, “should”, “potential”, “scheduled”, or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that there will be investor interest in future financings, market fundamentals will result in sustained precious metals demand and prices, the receipt of any necessary permits, licenses and regulatory approvals in connection with the future exploration and development of any future projects in a timely manner, the availability of financing on suitable terms for exploration and development of future projects and the Company’s ability to comply with environmental, health and safety laws.

The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors, including, operating and technical difficulties in connection with mineral exploration and development activities, actual results of exploration activities, the estimation or realization of mineral reserves and mineral resources, the inability of the Company to obtain the necessary financing required to conduct its business and affairs, as currently contemplated, the inability of the Company to enter into definitive agreements in respect of possible Letters of Intent, the timing and amount of estimated future production, the costs of production, capital expenditures, the costs and timing of the development of new deposits, requirements for additional capital, future prices of precious metals, changes in general economic conditions, changes in the financial markets and in the demand and market price for commodities, lack of investor interest in future financings, accidents, labour disputes and other risks of the mining industry, delays in obtaining governmental approvals, permits or financing or in the completion of development or construction activities, changes in laws, regulations and policies affecting mining operations, title disputes, the inability of the Company to obtain any necessary permits, consents, approvals or authorizations, including by the Exchange, the timing and possible outcome of any pending litigation, environmental issues and liabilities, and risks related to joint venture operations, and other risks and uncertainties disclosed in the Company’s latest interim Management’s Discussion and Analysis and filed with certain securities commissions in Canada. All of the Company’s Canadian public disclosure filings may be accessed via www.sedarplus.ca and readers are urged to review these materials.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update any of the forward-looking statements in this news release or incorporated by reference herein, except as otherwise required by law.

Forward-Looking Statements in This News Release

The following statements in this news release constitute forward-looking information:

• the Company’s plans to continue logging, photographing and sampling the GOH26-04 drill core and submitting samples for laboratory analysis;
• the Company’s current geological interpretation that the true thickness of the newly identified skarn intervals in GOH26-04 is approximately 40–45 metres, which is preliminary and may be refined as additional geological and drilling information becomes available;
• the completion of the fourth planned drill hole from Pad B at the Kuhn target;
• the Company’s plans to integrate observations from the latest drill holes, historical geological information and modern geophysical data to refine subsequent drill targeting;
• the expectation that the ongoing drill program will improve the Company’s understanding of the geometry, thickness and continuity of the skarn system at Kuhn, and the Company’s evaluation of skarn development beyond areas tested by historical drilling;
• the Company’s intention to evaluate additional priority targets across the broader Magno Project following the initial drilling focus at Kuhn;
• statements regarding the significance of the intersected skarn intervals, which will ultimately be determined by assay results; and
• the Company’s intention to provide further updates as drilling advances and as laboratory results are received, reviewed and verified.

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/cbc7d9bf-649c-4b67-a894-c05030ca595e
https://www.globenewswire.com/NewsRoom/AttachmentNg/3bde5835-e618-43c9-8f84-5cb90380be05